The PAPAA Forum: Coronavirus (COVID-19), Dr David Ashton
- Author: Dr David Ashton
- Topic: Coronavirus (COVID-19)
Sulfasalasine, a disease-modifying antirheumatic drug (DMARD), has a well-established role in the treatment of patients with chronic inflammatory diseases, such a rheumatoid arthritis, inflammatory bowel disease and psoriatic arthritis. It is often used in patients who are unable to tolerate methotrexate. Sulfasalasine has anti-inflammatory,…
- Author: Dr David Ashton
- Topic: Coronavirus (COVID-19)
COVID-19 remains a serious health risk. You should stay cautious to help protect yourself and others. The latest advice from the UK Government says:
- Let fresh air in if you meet indoors. Meeting outdoors is safer
- You must wear a face covering in shops and on all public transport (check local differences)
- Get tested and self-isolate, if required …
- Author: Dr David Ashton
- Topic: Coronavirus (COVID-19)
Introduction
One of the significant symptoms of Covid-19 is a persistent cough and, in severe cases, shortness of breath. Whilst this is not the place to discuss the specific features or details of coronavirus infection, it’s a useful moment to review the various lung conditions associated with psoriasis and whether any of the current systemic…
- Author: Dr David Ashton
- Topic: Coronavirus (COVID-19)
As the COVID-19 pandemic has continued, researchers have been able to study individual groups of patients with pre-existing medical conditions – including psoriasis. One especially important question, is whether patients diagnosed with psoriasis, could be more at risk of infection with COVID-19?
In a recent (virtual) meeting of the American…